Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Jun 6;10(6):732.
doi: 10.3390/nu10060732.

Dietary Salt Restriction in Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials

Carlo Garofalo  1 , Silvio Borrelli  2 , Michele Provenzano  3 , Toni De Stefano  4 , Carlo Vita  5 , Paolo Chiodini  6 , Roberto Minutolo  7 , Luca De Nicola  8 , Giuseppe Conte  9
Affiliations
Meta-Analysis

Dietary Salt Restriction in Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials

Carlo Garofalo et al. Nutrients. .

Abstract

Background: A clear evidence on the benefits of reducing salt in people with chronic kidney disease (CKD) is still lacking. Salt restriction in CKD may allow better control of blood pressure (BP) as shown in a previous systematic review while the effect on proteinuria reduction remains poorly investigated.

Methods: We performed a meta-analysis of randomized controlled trials (RCTs) evaluating the effects of low versus high salt intake in adult patients with non-dialysis CKD on change in BP, proteinuria and albuminuria.

Results: Eleven RCTs were selected and included information about 738 CKD patients (Stage 1⁻4); urinary sodium excretion was 104 mEq/day (95%CI, 76⁻131) and 179 mEq/day (95%CI, 165⁻193) in low- and high-sodium intake subgroups, respectively, with a mean difference of &minus;80 mEq/day (95%CI from &minus;107 to &minus;53; p <0.001). Overall, mean differences in clinic and ambulatory systolic BP were &minus;4.9 mmHg (95%CI from &minus;6.8 to &minus;3.1, p <0.001) and &minus;5.9 mmHg (95%CI from &minus;9.5 to &minus;2.3, p <0.001), respectively, while clinic and ambulatory diastolic BP were &minus;2.3 mmHg (95%CI from &minus;3.5 to &minus;1.2, p <0.001) and &minus;3.0 mmHg (95%CI from &minus;4.3 to &minus;1.7; p <0.001), respectively. Mean differences in proteinuria and albuminuria were &minus;0.39 g/day (95%CI from &minus;0.55 to &minus;0.22, p <0.001) and &minus;0.05 g/day (95%CI from &minus;0.09 to &minus;0.01, p = 0.013).

Conclusion: Moderate salt restriction significantly reduces BP and proteinuria/albuminuria in patients with CKD (Stage 1⁻4).

Keywords: blood pressure; chronic kidney disease; dietary salt restriction; proteinuria.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Flow-chart of study selection.
Figure 2
Figure 2
Mean difference of clinic and ambulatory blood pressure in low- and high-salt intake.
Figure 3
Figure 3
Mean difference of proteinuria, albuminuria, glomerular filtration rate, urinary sodium, urinary potassium and body weight in low- and high-salt intake.
Figure 4
Figure 4
Meta regression of differences in systolic blood pressure and overall unstandardized mean difference of six studies evaluating proteinuria. Y = −0.01 + (−0.05); p = 0.005.
See this image and copyright information in PMC

References

    1. Jha V., Garcia-Garcia G., Iseki K., Li Z., Naicker S., Plattner B., Saran R., Wang A.Y., Yang C.W. Chronic kidney disease: Global dimension and perspectives. Lancet. 2013;382:260–272. doi: 10.1016/S0140-6736(13)60687-X. - DOI - PubMed
    1. Radhakrishnan J., Remuzzi G., Saran R., Williams D.E., Rios-Burrows N., Powe N., Brück K., Wanner C., Stel V.S., Venuthurupalli S.K., et al. Taming the chronic kidney disease epidemic: A global view of surveillance efforts. Kidney Int. 2014;86:246–250. doi: 10.1038/ki.2014.190. - DOI - PMC - PubMed
    1. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004;351:1296–1305. doi: 10.1056/NEJMoa041031. - DOI - PubMed
    1. Palmer S.C., Maggo J.K., Campbell K.L., Craig J.C., Johnson D.W., Sutanto B., Ruospo M., Tong A., Strippoli G.F. Dietary interventions for adults with chronic kidney disease. Cochrane Database Syst. Rev. 2017;4:CD011998. doi: 10.1002/14651858.CD011998.pub2. - DOI - PMC - PubMed
    1. Ruggenenti P., Perticucci E., Cravedi P., Gambara V., Costantini M., Sharma S.K., Perna A., Remuzzi G. Role of remission clinics in the longitudinal treatment of CKD. J. Am. Soc. Nephrol. 2008;19:1213–1224. doi: 10.1681/ASN.2007090970. - DOI - PMC - PubMed

Substances